Met (phospho Tyr1003) Polyclonal Antibody

Catalog No.: 

Product Name: Met (phospho Tyr1003) Polyclonal Antibody

Catalog No.: ALP0916

Reactivity: Human;Mouse;Rat

Applications: WB;IHC-p;IF/ICC;ELISA

Source: Polyclonal, Rabbit,IgG

Formulation: Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide.

Concentration:1 mg/ml

Dilution: Western Blot: 1/500 – 1/2000. Immunohistochemistry: 1/100 – 1/300. Immunofluorescence: 1/200 – 1/1000. ELISA: 1/40000. Not yet tested in other applications.

Storage Stability: -20°C/1 year

Gene Name: MET

Protein Name: Hepatocyte growth factor receptor

Human Gene ID: 4233

Human Swiss Prot No.: P08581

Other Name: MET; Hepatocyte growth factor receptor; HGF receptor; HGF/SF receptor; Proto-oncogene c-Met; Scatter factor receptor; SF receptor; Tyrosine-protein kinase Met

Subcellular Location: Membrane; Single-pass type I membrane protein.; [Isoform 3]: Secreted.

Expression: Expressed in normal hepatocytes as well as in epithelial cells lining the stomach, the small and the large intestine. Found also in basal keratinocytes of esophagus and skin. High levels are found in liver, gastrointestinal tract, thyroid and kidney. Also present in the brain. Expressed in metaphyseal bone (at protein level) (PubMed:26637977).


Enzyme-Linked Immunosorbent Assay (Phospho-ELISA) for Immunogen Phosphopeptide (Phospho-left) and Non-Phosphopeptide (Phospho-right), using c-Met (Phospho-Tyr1003) Antibody


Immunofluorescence analysis of HepG2 cells, using c-Met (Phospho-Tyr1003) Antibody. The picture on the right is blocked with the phospho peptide.


Immunohistochemistry analysis of paraffin-embedded human colon carcinoma, using c-Met (Phospho-Tyr1003) Antibody. The picture on the right is blocked with the phospho peptide.


Western blot analysis of lysates from HepG2 cells, using c-Met (Phospho-Tyr1003) Antibody. The lane on the right is blocked with the phospho peptide.

For research use only. Not for use in diagnostic procedures.

Download SDS – English
Download SDS – Norwegian

Leave a Reply

Your email address will not be published. Required fields are marked *